Background. Bioincompatible peritoneal dialysis fluids (PDFs) cause pathological changes in the peritoneal membrane, related to membrane dysfunction and progressive peritoneal fibrosis. We investigated the effects of ProHis-Ser-Arg-Asn (PHSRN) peptide, one of the fibronectin cell-binding domains that activates integrins and reinforces wound healing, on peritoneal remodelling in a rat peritoneal injury model undergoing peritoneal dialysis. Methods. The peritoneal mesothelial monolayer was removed by a stripping procedure in rats receiving conventional high glucose-containing PDF supplemented with or without PHSRN or control His-Ser-Pro-Asn-Hrg (HSPNR) peptides. Effects of PHSRN on cell motility and signalling molecules were examined in cultured rat peritoneal mesothelial cells (RPMCs) and normal rat kidney fibroblasts (NRKs). Results. The cytokeratin-and HBME-1-positive mesothelial cell monolayer was selectively removed by the procedure. By day 6, HBME-1-positive cells had regenerated to 53.3 ± 6.5% of the peritoneal surface in the control group. Regeneration of the mesothelial layer was delayed in the PDF group (35.2 ± 10.2%, P < 0.05), but PHSRN reversed the effects of PDF (51.7 ± 9.6%, P < 0.05). PDF treatment increased thickening of granulomatous submesothelial tissue and numbers of ED1-, CD31-and α-smooth muscle actin-positive cells, but PHSRN ameliorated these effects. HSPNR had no effects on mesothelial regeneration or peritoneal wound healing. PHSRN, but not HSPNR, recovered glucose-induced inhibition of cell motility and phosphorylation of focal adhesion kinase and its downstream p130 Cas in RPMCs and NRKs. Conclusions. These results suggest that PHSRN has beneficial effects on peritoneal regeneration by reducing the inhibitory effects of conventional PDF on integrin-mediated wound healing.
Introduction
Long-term peritoneal dialysis (PD) is associated with pathological alterations of the peritoneal tissue, denudation of mesothelial cells, including tissue fibrosis, angiogenesis and hyalinising vasculopathy [1] [2] [3] . Such inappropriate peritoneal remodelling ultimately leads to peritoneal functional impairment such as ultrafiltration failure and progressive loss of dialysing capacity, requiring cessation of PD therapy [4] . In particular, mesothelial cells in the peritoneum are important as a permeability barrier, playing a crucial role in the regulation of local host defence mechanisms in the peritoneal cavity [5] . However, shedding and regeneration of the peritoneal mesothelial monolayer is continuous during PD in response to bioincompatible substances in non-physiological peritoneal dialysis fluids (PDFs) [6, 7] . Replacement of the mesothelial monolayer by acellular collagenous tissue is the most frequently described peritoneal morphological abnormality in long-term PD patients [8, 9] . High glucose concentrations in PDF suppress cell-cell and cell-extracellular matrix adhesions of mesothelial cells, followed by impaired regeneration of the mesothelial cell layer [10, 11] . Furthermore, acute peritoneal injuries induced by peritonitis exacerbate such peritoneal damage [12, 13] . A peritoneal dialysate that does not inhibit regeneration of the mesothelial tissue is thus needed.
Integrins are major adhesion receptors composed of pairs of α and β transmembrane subunits that mediate the specific association of cells with extracellular matrix such as fibronectin and that regulate cell motility and promote wound healing [14, 15] . In acute healing wounds, α5β1 integrin-mediated cell adhesion to fibronectin has been shown to be important for cell migration and reepithelialization [16] . In addition to the RGD (ArgGly-Asp) sequence that is well known as a fibronectin cell-binding domain, the PHSRN (Pro-His-Ser-Arg-Asn) sequence located in the ninth type III repeat of fibronectin was recently identified as a fibronectin peptide site that can interact with the α5β1 integrin [17] . The PHSRN se-quence is considered a modulatory site that facilitates the binding of fibronectin to integrins. The sequence displays potent local chemotactic and cell-invasive activities for promoting wound repair by activating the α5β1 integrin [17] [18] [19] [20] , which is constitutively expressed in a wide variety of cells, including human peritoneal mesothelial cells and fibroblasts [21, 22] . Interestingly, recent reports have shown that the PHSRN sequence accelerates integrinmediated dermal wound healing in diabetic mice [23] and promotes corneal wound healing by stimulating corneal epithelial migration [24, 25] . Strategies for reinforcing wound healing following peritoneal injury might help to identify novel methods for preventing peritoneal deterioration in patients on PD. We therefore designed the present study to identify the effects of PHSRN peptide on the wound-healing process in a rat peritoneal injury model undergoing PD therapy and to investigate possible mechanisms for effects of the peptide, focusing particularly on integrin-mediated cell migration and intracellular signalling.
Materials and methods

Materials
PHSRN peptide (Ac-PHSRN-NH 2 ) and HSPNR peptide (Ac-PHSRN-NH 2 ) were obtained from SIGMA Genosys (Ishikari, Japan). Monoclonal antibodies for HBME-1, α-smooth muscle actin (SMA) and cytokeratin were purchased from Dako (Glostrup, Denmark). Monoclonal antibody for ED1 (CD68), a marker for macrophages, was from Serotec (Oxford, UK). Polyclonal antibodies for α5 integrin and CD31, a marker for vascular endothelial cells, were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Labelled goat anti-rabbit immunoglobulin (Ig) G (Alexa Fluor ® 488) and anti-mouse antibodies (Alexa Fluor ® 546) were obtained from Invitrogen (Carlsbad, CA, USA). Monoclonal antibodies for focal adhesion kinase (FAK) and p130
Cas were obtained from BD Transduction Laboratories (Lexington, KY, USA). Rabbit polyclonal antibody against Y397-phosphorylated FAK was from BioSource International (Camarillo, CA, USA). Monoclonal anti-phosphotyrosine antibody (PY20) was from Sigma-Aldrich (St. Louis, MO, USA).
Rat experimental peritoneal injury model
Eight-week-old female Wistar rats (Japan Charles River, Yokohama, Japan) weighing 200-250 g were housed under conventional laboratory conditions of constant temperature at 22°C, with a 12-h light/dark cycle and ad libitum access to standard food and tap water. At day 0, under anaesthesia with pentobarbital sodium, rats were incised at the abdominal midline. The right abdominal walls were opened, and parietal peritoneal membranes with an area of about 1.5 cm 2 with mesothelial cell monolayer were peeled using tweezers and scissors. After the stripping procedure, abdominal walls were closely sutured. All surgical procedures were performed under sterile conditions. Rats were divided into four groups: Group 1, Earle's balanced salt solution (EBSS) adjusted to pH 7.4; Group 2, lactate-buffered PDF with 3.86% glucose at pH 5.5 (Dianeal ® PD-4 4.25; Baxter Healthcare, Tokyo, Japan); and Groups 3 and 4, PDF containing 100 μM of either PHSRN or HSPNR peptide, respectively, for six consecutive days followed by PDF without peptide for the remaining 6 days. Rats were injected with 20 ml of each fluid once a day using a 25-G sterile needle directly from the left abdominal wall away from the wound area. Parietal peritoneal tissues including the wound area were obtained for histological investigation under anaesthesia with pentobarbital sodium 1, 3, 6, 9 and 12 days postoperatively (n = 4 per group for days 1, 3 and 9; n = 6 for day 6; n = 8 for day 12; total 104 wounds). The protocol for the present study was approved by the Ethics Committee on Animal Care and Experimentation of the University of Occupational and Environmental Health (approval number, 07-035).
Histology and immunohistochemistry
Part of each obtained peritoneal specimen was fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2) for 24 h at 4°C, dehydrated through a graded ethanol series and embedded in paraffin using conventional techniques. Serial sections (5 μm) were stained with haematoxylin and eosin (HE) or Masson's trichrome for histological examination.
Immunohistochemical studies for HBME-1, αSMA, ED1 and CD31 were performed on paraffin-embedded specimens. Sections (5 μm) were deparaffinized, rehydrated, incubated for 20 min in 0.1% H 2 O 2 in methanol and incubated for 30 min in 1.5% bovine serum albumin in phosphate-buffered saline (PBS). Sections were then incubated for 18 h at 4°C with primary antibodies against HBME-1 (1:50), αSMA (1:50), ED1 (1:100) or CD31 (1:50). Sections were subsequently treated with streptavidin-conjugated peroxidase (Histofine Simple Stain; Nichirei, Tokyo, Japan). Finally, enzyme activity was visualized with 3,3′-diaminobenzidine tetrahydrochloride and H 2 O 2 , counterstained with haematoxylin, mounted and observed under an inverted microscope (AxioObserver; Carl Zeiss, Oberkochen, Germany). Negative control studies were performed using irrelevant Ig subclasses similar to those of the primary antibodies, such as nonspecific mouse IgG1 and rabbit IgG, instead of the primary antibodies. Immunofluorohistochemical study for cytokeratin and α5 integrin was performed on frozen specimens. Sections (5 μm) were fixed in 3% formaldehyde for 10 min. Tissue sections were permeabilized with 0.2% Triton X-100, and nonspecific protein-binding sites were blocked with 2% normal goat serum in PBS. Sections were incubated with antibodies against cytokeratin (1:100) or α5 integrin (1:100) for 18 h at 4°C. Alexa Fluor ® 546-conjugated goat anti-mouse IgG or Alexa Fluor ® 488-conjugated goat anti-rabbit IgG was applied at 1:200 dilution for 2 h as a secondary reagent. Sections were then coverslipped and examined using a confocal laser scanning microscope (LSM 5 PASCAL; Carl Zeiss).
Morphological analysis
To assess thickness of the wound area in the parietal peritoneum, distance from the surface mesothelium to the upper limit of the muscular tissue was measured using Axiovision for Windows version 4.6 software (Carl Zeiss). We measured peritoneal thickness at 10 random points and compared mean thickness of each tissue. Percentage area of the HBME-1-positive cell layer relative to total peritoneal surface area was calculated. The percentage area of αSMA-positive cells in thickened peritoneum was calculated using Axiovision Windows, and average areas at five random points in each tissue were calculated.
Cell culture
Rat peritoneal mesothelial cells (RPMCs) were obtained using a standard digestion method and maintained in Dulbecco's modified Eagle's medium (DMEM) (Sigma, Tokyo, Japan) supplemented with 10% fetal bovine serum and 0.1% glucose in humidified air with 5% CO 2 at 37°C, as described previously [11] . Cells were identified as RPMCs by a cobblestone appearance and positive staining for HBME-1 and cytokeratin. Normal rat kidney fibroblasts (NRKs) were purchased from the Riken BRC Cell Bank (Tsukuba, Japan).
Cell migration and proliferation assays
Cell migration was investigated using an in vitro wound-healing assay as described [11, 26, 27] . RPMCs and NRKs plated on 20 μg/ml ECL cell attachment matrix (Upstate Biotechnology Temecula, CA, USA)-coated Petri dishes were serum-starved overnight, and scratch wounds were created on confluent cell monolayers using a sterile pipette tip. Migration distance was calculated by subtracting the wound width at 24 h of incubation from the original wound width at 0 h in each medium using phasecontrast images of five random points in each well (n = 3). Cell numbers were quantified by chemiluminescence assay using a tetrazolium compound with CellTiter 96 ® AqueousOne Solution Reagent (Promega Corporation, Madison, WI, USA). RPMCs on a 96-well assay plate (n = 6) were incubated in DMEM with 10% fetal bovine serum for 24 h, followed by addition of indicated concentrations of glucose and/or peptides for 48 h. After three washes with PBS, cells were incubated with 20 μl of reagents and 100 μl of serum-free culture medium for 4 h at 37°C. Absorbance at Wound-healing process after peritoneal injury induced by stripping of the mesothelial cell monolayer. At day 0, mesothelial cell monolayer on rat parietal peritoneum was stripped as described in the Materials and methods. Tissue samples in the wound area obtained before, soon after, and 6 and 12 days after stripping were immunostained for HBME-1, ED1, CD31, cytokeratin and α5 integrin. Bars = 100 μm.
Integrin-activating peptide in peritoneal dialysis 1111 490 nm was measured using a plate reader, and the experiment was independently repeated three times. Hyaluronan levels in culture supernatants were measured using an Enzyme-linked-immunosorbent assay (ELISA) kit for hyaluronan (Echeron, Salt Lake City, UT, USA).
Western blotting and immunoprecipitation
Phosphorylation of FAK was analysed by western blotting using anti-phospho-FAK antibody, and phosphorylation of p130 Cas was determined by immunoprecipitation using anti-p130
Cas and phosphotyrosine antibodies as described [11, 28] . Cell lysates were prepared from RPMCs spread on 20 μg/ml ECL cell attachment matrix-coated Petri dishes for 2 h. Homogenates were resolved by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted using either antiphospho (Y397)-FAK antibody (1:1000) or total FAK antibody (1:500). Immunoprecipitation was performed using anti-p130
Cas antibody (4 μg/ ml), and immunoprecipitates were resolved by SDS-PAGE and analysed by western blotting with anti-phosphotyrosine (PY20, 1:2000) or antip130 Cas (1:1000) antibodies.
Statistical analysis
Data are expressed as mean ± standard deviation (SD). Differences between groups were examined for statistical significance using one-way analysis of variance or Student's t test. Values of P < 0.05 were considered statistically significant.
Control PDF PDF+PHSRN PDF+HSPNR
Relative HBME-1-positive area (%) Effects of PHSRN on remesothelialization after peritoneal injury in rats on PD. (A) After peritoneal injury, rats intraperitoneally received buffer (control) or PDF with or without PHSRN or HSPNR peptides as described in the Materials and methods. Regeneration of the mesothelial cell monolayer was examined by immunohistochemistry for HBME-1 at 1, 3, 6, 9 and 12 days after stripping. Bars = 50 μm. (B) Relative HBME-1-positive area was calculated by the ratio of HBME-1-positive area against the total peritoneal surface area. Values represent mean ± SD. *P < 0.05 vs PDF group. Integrin-activating peptide in peritoneal dialysis 1113
Results
Wound healing after peritoneal injury induced by stripping procedure
Wound-healing processes were histologically examined after a procedure to strip peritoneal mesothelial monolayers in the EBSS-treated group (control group, Figure 1) . Before stripping, an HBME-1-and cytokeratin-positive mesothelial cell monolayer was observed on the surface of the peritoneal tissue. Histological examination soon after the procedure confirmed removal of the mesothelial cell layer. After 6 days, granulomatous tissue formation was observed in the submesothelial area consisting of loose connective tissue, including ED1-positive mononuclear round cells and new CD31-positive blood vessels. Partial regeneration of the HBME-1-and cytokeratin-positive cell monolayer and increased staining for α5 integrin in both the mesothelial surface and submesothelial area were also observed. Contracted wound tissue was observed on day 12, mainly comprising spindle-shaped cells and collagenous matrix with the regenerated mesothelial monolayer.
Effects of PHSRN on regeneration of the mesothelial cell layer after peritoneal injury induced by stripping
The effects of PHSRN on regeneration of the mesothelial cell monolayer were examined 1, 3, 6, 9 and 12 days after stripping by immunohistochemical staining for HBME-1.
Representative photographs are shown in Figure 2A . At day 6, HBME-1-positive mesothelial cell layer areas were regenerated to 53.3 ± 6.5% in the control group, whereas regeneration of the mesothelial layer was delayed in the PDF group (35.2 ± 10.2%, P < 0.05). Interestingly, the HBME-1-positive mesothelial layers in rats treated with PDF containing 100 μM PHSRN was increased to 51.7 ± 9.6 and 74.8 ± 13.7% at days 6 and 9, respectively (P < 0.05 vs PDF group, not significant vs control group) ( Figure  2B ). HSPNR, an inactive random peptide, had no effects on mesothelial regeneration. At 12 days after stripping, regeneration of mesothelial cell monolayers was almost complete in all four groups, and no significant differences were found between groups.
Effects of PHSRN on histological changes in the submesothelial area
We next examined histological features of the wound area of the peritoneal membrane by HE staining. Representative photographs are shown in Figure 3A . At day 12, spindleshaped cells arranged in the contracted connective tissue layer parallel to the wound surface were observed in controls. In the PDF group, numerous round cells were observed in the thickened submesothelial space forming granulomatous tissue, suggesting an earlier wound healing stage compared with tissue in the control group [29] . However, in the PHSRN group, but not in the HSPNR group, the majority of cells in the tissue were spindle-shaped cells as seen in controls, and the wound area mainly comprised contracted connective tissue with a fine lining of collagen fibres.
Following re-epithelialization and wound closure, the wound-healing process involves extracellular matrix degradation, decreased cellularity and constitution of scar tissue [30] . At the early stage of wound healing (days 3 and 6), cell numbers in the submesothelial area were decreased in the PDF and HSPNR groups, but cell numbers in the wound were clearly higher in the PDF group (70.0 ± 20.1 per 100 μm 2 area) than in controls (40.4 ± 8.6 per 100 μm 2 area; P < 0.01) at the wound closure stage (day 12) (Figure 3B ). Similarly, cell numbers were decreased in the PHSRN group (44.5 ± 16.0, P < 0.01 vs PDF group, not significant vs control group), but not in the HSPNR group, suggesting that PHSRN attenuates the inhibitory effects of PDF on peritoneal wound healing.
Effects of PHSRN on peritoneal thickness and ED1-and CD31-positive cells
We subsequently compared thicknesses of the submesothelial compact zone ( Figure 4A ), ED1-positive macrophage infiltration ( Figure 4B ) and CD31-positive vessels ( Figure 4C ) in the wound area to assess the wound-healing process in each group after peritoneal injury. On day 12, mean peritoneal thickness was higher in the PDF group (112.8 ± 18.5 μm) than in controls (77.3 ± 10.6 μm, P < 0.01), but PHSRN abrogated the effects of PDF (84.8 ± 11.3 μm, P < 0.05 vs PDF group). By day 6, increased numbers of ED-1-positive macrophages were identified in the control and PHSRN groups, but a faster decline was subsequently observed in these groups. On day 12, PHSRN decreased the number of ED1-positive macrophages (39.1 ± 7.1/field vs 56.6 ± 7.0/field in the PDF group, P < 0.05) and CD31-positive vessels (4.5 ± 1.1/field vs 7.2 ± 2.3/field in the PDF group, P < 0.05) in the wound area. Mean thickness and numbers of macrophages and vessels in wounds of the HSPNR group (108.7 ± 14.2 μm, 54.9 ± 5.8/field, 8.3 ± 1.4/ field, respectively) were comparable to those in the PDF group.
Effects of PHSRN on αSMA expression in the submesothelial area
To investigate the involvement of myofibroblasts in the wound-healing process, we examined αSMA expression after stripping using immunohistochemistry for αSMA. Representative immunostainings for αSMA at day 12 are shown in Figure 5A . Cells showing positive results for αSMA appeared on day 3 in the wound area and reached maximal levels at days 6-9 without significant differences among groups ( Figure 5A ). On day 12, the submesothelial wound area in the PDF group retained significantly more αSMA-positive cells than the control group (30.6 ± 3.3 and 12.1 ± 2.9%, respectively, P < 0.01), suggesting delayed wound repair. Significantly fewer αSMA-positive cells in the wound were seen for the PHSRN group compared to the PDF group (18.8 ± 6.5%, P < 0.05 vs PDF group, P = 0.18 vs control group). HSPNR (28.7 ± 6.8%) had no effects on αSMA expression. 1114 T. Miyamoto et al.
Effects of PHSRN on cell migration in cultured RPMCs and NRKs
We further investigated possible mechanisms underlying the protective effects of PHSRN on regeneration of peritoneal tissue by in vitro wound healing using cultured RPMCs and NRKs. PHSRN increased cell migration in a concentration-dependent manner, with a peak at 10 2 -10 3 nM ( Figure 6A and B) . In contrast, HSPNR had no effects on cell migration. We have previously reported that high glucose concentrations inhibit integrin-mediated migration of mesothelial cells [11] . We therefore also examined the effects of PHSRN on glucose-induced inhibition of cell migration. Although glucose retarded cell migration for both cell types (RPMCs, 45.0 ± 3.6%, P < 0.001; NRKs, 48.8 ± 4.2%, P < 0.001, vs medium with no glucose or peptides), PHSRN partially rescued the inhibitory effects of glucose (RPMCs, 67.0 ± 5.4%, P < 0.05; NRKs, 80.4 ± 11.0%, P < 0.05, vs medium with glucose without peptides) (Figure 6C and D) . HSPNR had no effects on glucose-induced suppression of cell migration (RPMCs, 41.3 ± 3.6%; NRKs, 51.8 ± 4.4%, respectively).
Effects of PHSRN on cell proliferation and hyaluronan excretion
As high glucose levels inhibit cell proliferation and induce apoptosis after long-term exposure [11] , these effects of PHSRN on cell migration might stem from increased cell proliferation. We therefore examined the effects of PHSRN on cell proliferation, to further exclude the effects of cell growth on wound healing by PHSRN. Although high glucose concentrations inhibited cell proliferation (33.9 ± 6.4%, P < 0.001, vs medium with no glucose or peptides), both PHSRN and HSPNR had no significant effects on cell number, irrespective of the presence of glucose in culture medium (Figure 7) , suggesting that the accelerating effect of PHSRN on remesothelialization does not depend on cell proliferation.
Hyaluronan is excreted by peritoneal mesothelial cells and plays an important role in mesothelial cell migration T. Miyamoto et al. [31] . PHSRN peptide showed no significant effects on hyaluronan levels in culture supernatants after 24-h incubation of RPMCs with or without glucose (Figure 8 ), suggesting that hyaluronan is not involved in the PHSRN induced-acceleration of peritoneal wound healing.
Effects of PHSRN on phosphorylation levels of FAK and p130
Cas
Cell interactions with extracellular matrix proteins through integrin receptors can mediate transmembrane signal transduction. FAK is a key molecule in integrin-mediated regulation of cell migration [32, 33] . We further investigated the mechanism of PHSRN in peritoneal tissue remodelling by examining activities of integrin-mediated signal transduction molecules in cultured RPMCs. High glucose concentrations suppressed tyrosine phosphorylation of FAK after cell adhesion to the extracellular matrix. PHSRN, but not HSPNR, offsets the inhibitory effects of glucose on FAK phosphorylation ( Figure 9A ). The p130 Cas adaptor protein is a downstream effector of FAK-promoted cell spreading and migration [35, 36] . Again, tyrosine phosphorylation levels of p130
Cas were significantly repressed by high concentrations of glucose. PHSRN, but not HSPNR, attenuated the inhibitory effects of glucose on p130
Cas phosphorylation ( Figure 9B ), suggesting that PHSRN restores peritoneal wound healing by activating integrin-mediated intracellular signalling suppressed by glucose-containing PDF. The most major integrin that is ubiquitously expressed (including mesothelial cells) is α5β which plays a critical role in cell migration [18] . We examined α5β integrin expression levels in RPMCs by western blotting. PHSRN had no effect on the expression of α5β1 integrin (data not shown).
Discussion
The present study showed that conventional lactate-buffered PDF containing 3.86% glucose retarded regeneration of peritoneal tissue after peritoneal injury induced by stripping of the mesothelium. PHSRN offsets the suppressive effects of PDF on wound healing, including remesothelialization. Furthermore, PHSRN promoted migration of RPMCs and NRKs and abrogated the inhibitory effects of high glucose concentrations on cell migration, but not on cell proliferation and hyaluronan excretion, associated with increases in phosphorylation levels of FAK and p130
Cas . These results provide the first evidence that PHSRN promotes peritoneal wound healing by modulating integrin-mediated cell signalling, consistent with reported effects of the peptide on skin [23] and corneal tissue [24] .
Denudation of the mesothelial cell monolayer is frequently observed on the peritoneal membrane in patients chronically exposed to dialysis fluid [2, 3] . Instillation of acidic PDF into rat peritoneal cavity also reportedly induces overexpression of α5β1 integrin in mesothelial cells [37] . In the present study, expression of α5β1 integrin increased in mesothelial cells, and remesothelialization was enhanced by PHSRN after peritoneal injury. These results suggest that PHSRN may facilitate regeneration of remain- Integrin-activating peptide in peritoneal dialysis 1117
ing mesothelial cells around denuded areas by increasing cell motility. Neovascularization and phenotypic changes to myofibroblasts in response to tissue injury normally disappear gradually in the resolution phase of wound healing, and fibroblasts surviving in the wound area after wound closure revert to a more quiescent phenotype [30, 38, 39] . However, in patients on PD, bioincompatible substances in the PDF could conceivably keep cells in a more active mesenchymal phenotype after episodes of peritoneal injury [40, 41] , ultimately exacerbating inappropriate peritoneal tissue remodelling. We observed that delayed wound contraction and increased αSMA expression in the submesothelial area were decreased by initial PHSRN administration. PHSRN might thus have therapeutic potential not only for regeneration of the mesothelial monolayer but also for decreasing the exacerbation of peritoneal deterioration after episodes of acute peritoneal injury. However, the present study was limited in that we did not observe long-term effects of the peptide on peritoneal histology or peritoneal functions such as ultrafiltration and solute transport. As imbalances of synthesis and degradation of fibronectin could lead to tissue sclerosis or fibrosis [42, 43] , long-term administration of PHSRN into the peritoneal cavity might elicit detrimental effects on peritoneal tissues. Although we found that short-term instillation of the peptide induced no excessive scar formation in peritoneal tissue, further investigations are necessary to confirm longterm effects of the peptide.
In conclusion, the present study showed that the integrin-activating peptide PHSRN exerts beneficial effects on peritoneal regeneration following peritoneal injury by reducing the inhibitory effects of glucose-containing conventional PDF on integrin-mediated wound healing. This study provides a possible novel strategy for preventing peritoneal deterioration in PD patients by focusing on the wound-healing process after injury. Cas phosphorylation. Total cell lysates were obtained from serum-starved RPMCs spread on extracellular matrix-coated dishes for 2 h in 140 mM glucose-containing culture medium with or without 100 nM PHSRN or 100 nM HSPNR peptides, immunoblotted with either anti-phospho-FAK or total FAK antibodies (A). Alternatively, total cell lysates were immunoprecipitated with antip130
Cas antibody and immunoblotted with anti-phosphotyrosine or antip130
Cas antibodies (B). Relative FAK or p130 Cas phosphorylation levels were determined by densitometric analysis and expressed as a relative ratio of phospho-FAK or p130
Cas to total FAK or p130 Cas , respectively. Values represent mean ± SD from four independent experiments for FAK and three experiments for p130
Cas . *P < 0.05 vs medium containing 140 mM glucose with no peptide.
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